DENVER, Colorado — August 25, 2020 — OncBioMune d/b/a Theralink Technologies (OTC: OBMP) (“Theralink” or the “Company...
Mr. Fanelli joins the Theralink® team having previously held positions at Metabolon Inc., Core Diagnostics, Nanostring...
Theralink® Technologies Announces Strategic Agreement with VieCure to Improve Outcomes for Breast Cancer Patients Being...
Golden, Colorado – June 17, 2020 – OncBioMune (OTC: OBMP) d/b/a Theralink Technologies, a molecular profiling compan...
Golden, Colorado - June 10, 2020 - OncBioMune Pharmaceuticals, Inc. (OTC: OBMP) (“OncBioMune”) today announced the a...
Avant Diagnostics provides personalized medicine data for physicians and measures the activation state of key drug targets...